An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system

Vaccine

Volumn 28, Issue 19, 2010, Pages 3318-3324

  Orlinger, Klaus K ^a   Holzer, Georg W ^a   Schwaiger, Julia ^a   Mayrhofer, Josef ^a   Schmid, Karl ^a   Kistner, Otfried ^a   Noel Barrett, P ^a   Falkner, Falko G ^a  

^a BAXTER BIOSCIENCE   (Austria)

Author keywords

Gene synthesis; Vaccine; West Nile Virus

Indexed keywords

COMPLEMENTARY DNA; INACTIVATED VIRUS VACCINE; NEUTRALIZING ANTIBODY; VIRUS DNA; VIRUS PROTEIN; VIRUS RNA; WEST NILE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA SEQUENCE; DRUG EFFICACY; DRUG SYNTHESIS; FEMALE; GENE SYNTHESIS; GENETIC TRANSFECTION; IMMUNOSTIMULATION; IN VITRO STUDY; INSECT CELL; MAMMAL CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIROGENESIS; VIRUS GENOME; VIRUS VIRULENCE; WEST NILE FLAVIVIRUS; WILD TYPE;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; DNA, COMPLEMENTARY; FEMALE; GENOME, VIRAL; INSECTS; MICE; MICE, INBRED BALB C; RNA, VIRAL; SURVIVAL ANALYSIS; TRANSFECTION; VACCINES, INACTIVATED; VIRAL VACCINES; VIRULENCE; WEST NILE FEVER; WEST NILE VIRUS;

EID: 77950518047     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.02.092     Document Type: Article

References (36)

1. Mackenzie J.S., Gubler D.J., and Petersen L.R. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis. West Nile and dengue viruses. Nat Med 10 December (12 Suppl.) (2004) S98-S109
2. Lindenbach B.D., and Rice C.M. Flaviviridae: the viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fields virology. 4th ed. (2001), Lippincott Williams & Wilkins, Philadelphia, PA
3. Ruggli N., and Rice C.M. Functional cDNA clones of the Flaviviridae: strategies and applications. Adv Virus Res 53 (1999) 183-207
4. Bredenbeek P.J., Kooi E.A., Lindenbach B., Huijkman N., Rice C.M., and Spaan W.J. A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication. J Gen Virol 84 May (Pt 5) (2003) 1261-1268
5. Campbell M.S., and Pletnev A.G. Infectious cDNA clones of Langat tick-borne flavivirus that differ from their parent in peripheral neurovirulence. Virology 269 March (1) (2000) 225-237
6. Gualano R.C., Pryor M.J., Cauchi M.R., Wright P.J., and Davidson A.D. Identification of a major determinant of mouse neurovirulence of dengue virus type 2 using stably cloned genomic-length cDNA. J Gen Virol 79 March (Pt 3) (1998) 437-446
7. Hurrelbrink R.J., Nestorowicz A., and McMinn P.C. Characterization of infectious Murray Valley encephalitis virus derived from a stably cloned genome-length cDNA. J Gen Virol 80 December (Pt 12) (1999) 3115-3125
8. Kapoor M., Zhang L., Mohan P.M., and Padmanabhan R. Synthesis and characterization of an infectious dengue virus type-2 RNA genome (New Guinea C strain). Gene 162 September (2) (1995) 175-180
9. Khromykh A.A., and Westaway E.G. Completion of Kunjin virus RNA sequence and recovery of an infectious RNA transcribed from stably cloned full-length cDNA. J Virol 68 July (7) (1994) 4580-4588
10. Kinney R.M., Butrapet S., Chang G.J., Tsuchiya K.R., Roehrig J.T., Bhamarapravati N., et al. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 230 April (2) (1997) 300-308
11. Lai C.J., Zhao B.T., Hori H., and Bray M. Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proc Natl Acad Sci USA 88 June (12) (1991) 5139-5143
12. Liu W.J., Chen H.B., and Khromykh A.A. Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication. J Virol 77 July (14) (2003) 7804-7813
13. Mandl C.W., Ecker M., Holzmann H., Kunz C., and Heinz F.X. Infectious cDNA clones of tick-borne encephalitis virus European subtype prototypic strain Neudoerfl and high virulence strain Hypr. J Gen Virol 78 May (Pt 5) (1997) 1049-1057
14. Pierro D.J., Salazar M.I., Beaty B.J., and Olson K.E. Infectious clone construction of dengue virus type 2, strain Jamaican 1409, and characterization of a conditional E6 mutation. J Gen Virol 87 August (Pt 8) (2006) 2263-2268
15. Pletnev A.G. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3′ deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice. Virology 282 April (2) (2001) 288-300
16. Polo S., Ketner G., Levis R., and Falgout B. Infectious RNA transcripts from full-length dengue virus type 2 cDNA clones made in yeast. J Virol 71 July (7) (1997) 5366-5374
17. Puri B., Polo S., Hayes C.G., and Falgout B. Construction of a full length infectious clone for dengue-1 virus Western Pacific, 74 strain. Virus Genes 20 1 (2000) 57-63
18. Rice C.M., Grakoui A., Galler R., and Chambers T.J. Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. New Biol 1 December (3) (1989) 285-296
19. Shi P.Y., Tilgner M., Lo M.K., Kent K.A., and Bernard K.A. Infectious cDNA clone of the epidemic west nile virus from New York City. J Virol 76 June (12) (2002) 5847-5856
20. Sumiyoshi H., Hoke C.H., and Trent D.W. Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates. J Virol 66 September (9) (1992) 5425-5431
21. Yamshchikov V.F., Wengler G., Perelygin A.A., Brinton M.A., and Compans R.W. An infectious clone of the West Nile flavivirus. Virology 281 March (2) (2001) 294-304
22. Yamshchikov V., Mishin V., and Cominelli F. A new strategy in design of +RNA virus infectious clones enabling their stable propagation in E. coli. Virology 281 March (2) (2001) 272-280
23. Cello J., Paul A.V., and Wimmer E. Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science 297 August (5583) (2002) 1016-1018
24. Wimmer E., Mueller S., Tumpey T.M., and Taubenberger J.K. Synthetic viruses: a new opportunity to understand and prevent viral disease. Nat Biotechnol 27 December (12) (2009) 1163-1172
25. Kofler R.M., Hoenninger V.M., Thurner C., and Mandl C.W. Functional analysis of the tick-borne encephalitis virus cyclization elements indicates major differences between mosquito-borne and tick-borne flaviviruses. J Virol 80 April (8) (2006) 4099-4113
26. Stadler K., Allison S.L., Schalich J., and Heinz F.X. Proteolytic activation of tick-borne encephalitis virus by furin. J Virol 71 November (11) (1997) 8475-8481
27. Pijlman G.P., Suhrbier A., and Khromykh A.A. Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications. Expert Opin Biol Ther 6 February (2) (2006) 135-145
28. Guy B., Guirakhoo F., Barban V., Higgs S., Monath T.P., and Lang J. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses. Vaccine October (2009)
29. Wimmer E. The test-tube synthesis of a chemical called poliovirus. EMBO Rep 7 (2006) 3-9
30. Smith H.O., Hutchison III C.A., Pfannkoch C., and Venter J.C. Generating a synthetic genome by whole genome assembly: phiX174 bacteriophage from synthetic oligonucleotides. Proc Natl Acad Sci USA 100 December (26) (2003) 15440-15445
31. Tumpey T.M., Basler C.F., Aguilar P.V., Zeng H., Solorzano A., Swayne D.E., et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310 October (5745) (2005) 77-80
32. Becker M.M., Graham R.L., Donaldson E.F., Rockx B., Sims A.C., Sheahan T., et al. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proc Natl Acad Sci USA 105 December (50) (2008) 19944-19949
33. Drake J.W., Charlesworth B., Charlesworth D., and Crow J.F. Rates of spontaneous mutation. Genetics 148 April (4) (1998) 1667-1686
34. Eigen M. Viral quasispecies. Sci Am 269 July (1) (1993) 42-49
35. CDC. Select Agents List. Available from: http://www.cdc.gov/od/sap/docs/salist.pdf.
36. NSABB. National Science Advisory Board for Biosecurity. Addressing biosecurity concerns related to the synthesis of select agents (2006), NIH